Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

2009 Scientific Articles

Batra J, Eriksen E, Zangwill K, Lee M, Marcy S, Ward J for the Vaccine Safety Datalink. Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care population. Pediatrics 2009;123(3):951-958.

Belongia EA, Irving SA, Shui IM, Kulldorf M, Lewis E, Yin R, Lieu TA, Weintraub E, Yih WK, Li R, Baggs, J. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pedatri Infect Dis J 2009.

Bonhoeffer J, Bentsi-Echnill, Chen R, Fisher M, Gold M, Hartman K, Heininger U, Hoet B, Jefferson T, Khuri-Bulos N, Kohl K, Marcy M, Nalin D, Pless R, Sanabria-Rojas H, Sleeman K, Wise R. Guidelines for collection, analysis, and presentation of vaccine safety data in pre- and post-licensure clinical studies. Vaccine 2009 April 6:27(16):2282-8.

Centers for Disease Control and Prevention (CDC). Safety of Influenza A (H1N1) 2009 Monovalent Vaccines--United States, October 1--November 24, 2009. MMWR 2009 11 Dec; 58(48):1351-1356.

Donahue JG, Kieke BA, Yih WK, Berger NR, McCauley JS, Baggs J, Zangwill KM, Baxter R, Eriksen EM, Glanz JM, Hambidge SJ, Klein NP, Lewis EM, Marcy SM, Naleway AL, Nordin JD, Ray P, Belongia EA for the Vaccine Safety Datalink Team. Varicella vaccination and ischemic stroke in children: Is there an Association? Pediatrics 2009; 123;228–234.

Durbin AP, Setse R, Omer SB, Palmer JG, Spaeder JA, Baker J, Lessans F, and Halsey NA. Monitoring Adverse Events Following Yellow Fever Vaccination Using an Integrated Telephone and Internet-based System. Vaccine 2009 Oct 19; 27(44):6143-47.

Fiore AE, Shay DK, Broder K, Iskander J, Uyeki TM, Mootrey G, Bresee JS, Cox NJ. Prevention and control of seasonal influenza. MMWR. 2009: July 24 (58); 1-52.

Greene SK, Kulldorff M, Lewis EM, Li R, Ruihua Y, Weintraub ES, Fireman BH, Lieu TA, Nordin JD, Glanz JM, Baxter R, Jacobsen SJ, Broder KR, Lee GM. Near real-time surveillance for influenza vaccine safety: proof of concept in the Vaccine Safety Datalink Project. American Journal of Epidemiology 2009.

Greene SK, Shi P, Dutta-Linn MM, Shoup JA, Hinrichsen VL, Ray P, Nordin JD, Kuckler L, Weintraub ES, Yih WK. Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites. Am J Prev Med. 2009 Dec;37(6):552-5.

Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barré syndrome. Drug Safety. 2009; 32(4):309-23. doi: 10.2165/00002018-200932040-00005.

Hazlehurst B, Naleway A, Mullooly J. Detecting possible vaccine adverse events in clinical notes of the electronic medical record. Vaccine 27 (2009) 2077–2083.

Jackson LA, Yu Onchee, Nelson J, Belongia EA, Hambidge SJ, Baxter R, Naleway A, Nordin J, Baggs J, Iskander J. Risk of medically-attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: A Vaccine Safety Datalink Study. Vaccine. 2009:27:4912-4916.

Jackson LA, Onchee Y, Belongia EA, Hambidge SJ, Nelson J, Baxter R, Naleway A, Gay C, Nordin J, Baggs J, and Iskander J. Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study. BMC Infect Dis. 2009; 9: 165.

Jackson LA, Baxter R, Naleway AL, Belongia EA, Baggs J. Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study. BMC Infect Dis. 2009 Mar25;9(1):37.May;127(5):e1139-46.

Klein NP, Edwards KM, Sparks R and Dekker CL; on behalf of the Clinical Immunization Safety Assessment (CISA) Network. Recurrent Sterile Abscesses Following Immunization: A Possible Association with Aluminum Adjuvant. BMJ Case Reports. 2009.

Klein NP, Kissner J, Aguirre A, Sparks R, Campbell S, Edwards KM, Dekker CL, Shui I, Gust DA. Differential Maternal Responses to a Newly Developed Vaccine Information Pamphlet. Vaccine 2009; 28:323–8.

Naleway AL, Belongia EA, Donahue JG, Kieke BA, Glanz JM: Vaccine Safety Datalink. Risk of immune hemolytic anemia in children following immunization. Vaccine. 2009 Dec 9;27(52):7394-7.

Nelson JC, Bittner RCL, Bounds L, Zhao S, Baggs J, Donahue JG, Hambidge SJ, Jacobsen SJ, Klein NP, Naleway AL, Zangwill KM, Jackson LA. Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a Vaccine Safety Datalink Study. Am J Public Health 2009 Oct:99 Suppl 2:S389-97.

Rue-Cover A, Iskander J, Lyn S, Burwen DR, Gargiullo P, Shadomy S, Blostein J, Bridges CB, Haber P, Satzger RD, Ball R, Seward JF. Death and serious illness following influenza vaccination: a multidisciplinary investigation. Pharmacoepidemiol and Drug Safety. 2009; 18(6):504-11.

Rosenberg M, Sparks R, McMahon A, Iskander J, Campbell JD, and Edwards KM. Serious Adverse Events Rarely Reported After Trivalent Inactivated Influenza Vaccine (TIV) in Children 6–23 Months of Age. Vaccine. 2009 Jul 9; 27(32):4278-83.

Rue-Cover A, Iskander J, Lyn S, Burwen DR, Gargiullo P, Shadomy S, Blostein J, Bridges CB, Satzger RD, Ball R, Seward JF. Death and serious illness following influenza vaccination: a multidisciplinary investigation. Pharmacoepidemiol Drug Safety 2009: April 16.

Shui I, Ping Shia, M. Maya Dutta-Linn, Eric S.Weintraub, Simon J. Hambidge, James D. Nordin, Tracy A. Lieu, for the Vaccine Safety Datalink Research Team. Predictive value of seizure ICD-9 codes for vaccine safety research. Vaccine 27 (2009) 5307–5312.

Tate J, Curns A, Cortese M, Weintraub E, Hambidge S, Zangwill K, Patel M, Baggs J, Parashar U. Burden of acute gastroenteritis hospitalizations and emergency department visits in U.S. children that is totally preventable by rotavirus vaccination: a probe study using the now-withdrawn RotaShield vaccine. Pediatrics 2009;123(3):744-9.

Tozzi AE, Bisiacchi P, Tarantino V, De Mei B, D'Elia L, Chariotti F, Salmaso S. Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines. Pediatrics 2009; 123;475–482.

Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine 2009;1:125.

Wei F, Mullooly JP, Goodman M, McCarty MC, Hanson AM, Crane B, Nordin JD. Identification and characteristics of vaccine refusers. BMC Pediatr. 2009 Mar 5;9:18

Yih WK, Nordin JD, Kulldorff M, Lewis E, Lieu TA, Shi P, Weintraub ES. An assessment of the safety of adolescent and adult tetanus–diphtheria–acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine 27 (2009) 4257–4262.

Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    TTY: (888) 232-6348
  • Contact CDC–INFO The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #